Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WRAP: Rivaroxaban and Apixaban vs Warfarin in Left Ventricular Thrombus
NCT05973188Phase 4Unknown
- Sponsor
- Peshawar Institute of Cardiology
- Start
- May 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, apixaban in left ventricular thrombus (LVT), sponsored by Peshawar Institute of Cardiology. Status: unknown.
02
Drugs
rivaroxabanapixaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT05973188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973188.